Status:
COMPLETED
Patient and Provider Attitudes in the Healthcare Context
Lead Sponsor:
VA Office of Research and Development
Conditions:
Diabetes Mellitus
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research study is to assess patient and provider attitudes towards the role that patients should play in medical decision making and self-management. We will examine the degree to ...
Detailed Description
Previous work has shown that similarities in patients' and providers' beliefs about the role each should play in health care contexts are associated with greater patient satisfaction, greater trust in...
Eligibility Criteria
Inclusion
- Patients enrolled in primary care clinics at the study sites (Iowa City VAMC, Jesse Brown VAMC - Chicago) who are scheduled to be seen by a participating provider in the next three (3) months and have been seen on at least three (3) additional occasions by that same
- provider in the prior 24 months. Participating patients must also:
- i) have prior diagnoses of both HTN and DM, as documented in VA administrative files;
- ii) have an active prescription for an anti-hypertensive medication in the following medication classes: thiazide diuretic, beta blocker, angiotensin converting enzyme (ACE) inhibitor, angiotensin receptor blocker (ARB), calcium channel blocker, or alpha blocker;
- iii) have an active prescription for an oral hypoglycemic agent or for an insulin preparation;
- iv) be able to provide informed consent;
- v) have a home telephone; and
- vi) reside in an independent living environment and not in a skilled care facility.
Exclusion
- i) cognitive impairment;
- ii) severe underlying illness, including: metastatic cancer, active treatment for any malignancy (excluding basal and squamous cell skin cancers), end-stage renal disease, cirrhosis, severe chronic obstructive lung disease requiring home oxygen therapy, and congestive
- heart failure with a documented left ventricular ejection fraction of less than 35% or a prior echocardiogram denoting "severe" left ventricular dysfunction; and
- iii) visits in the prior 18 months to a VA endocrinology, cardiology, or nephrology clinic.
Key Trial Info
Start Date :
June 4 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00404027
Start Date
June 4 2007
End Date
October 1 2010
Last Update
June 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iowa City VA Health Care System, Iowa City, IA
Iowa City, Iowa, United States, 52246-2208